Individualizing Adjuvant Therapy in Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Node-Positive Breast Cancer

JCO Oncol Pract. 2022 Apr;18(4):247-251. doi: 10.1200/OP.21.00780. Epub 2022 Feb 2.

Authors

Keerthi Gogineni¹, Kevin Kalinsky¹

Affiliation

¹ Emory School of Medicine, Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.

PMID: 35108074
DOI: 10.1200/OP.21.00780

No abstract available

Publication types

Editorial

MeSH terms

Breast Neoplasms* / therapy
Female
Humans
Receptor, ErbB-2 / metabolism

Substances

ERBB2 protein, human
Receptor, ErbB-2